Traws Pharma, Inc.: operating cash flow
Operating cash flow for Traws Pharma, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Traws Pharma, Inc. financial histories
What this measure means
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
Exact concept: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2016-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | -18,185,000 | USD | 2026-04-15 | 10-K · 0001104659-26-043832 |
| 2024-01-01 | 2024-12-31 | -29,792,000 | USD | 2026-04-15 | 10-K · 0001104659-26-043832 |
| 2023-01-01 | 2023-12-31 | -17,932,000 | USD | 2025-03-31 | 10-K · 0001558370-25-004165 |
| 2022-01-01 | 2022-12-31 | -16,294,000 | USD | 2024-04-01 | 10-K · 0001558370-24-004525 |
| 2021-01-01 | 2021-12-31 | -19,487,000 | USD | 2023-03-30 | 10-K · 0001558370-23-005107 |
| 2020-01-01 | 2020-12-31 | -23,075,000 | USD | 2022-03-21 | 10-K · 0001558370-22-004015 |
| 2019-01-01 | 2019-12-31 | -20,831,000 | USD | 2021-03-18 | 10-K · 0001104659-21-038452 |
| 2018-01-01 | 2018-12-31 | -22,696,000 | USD | 2020-03-27 | 10-K · 0001047469-20-001878 |
| 2017-01-01 | 2017-12-31 | -23,820,000 | USD | 2019-04-01 | 10-K · 0001047469-19-001839 |
| 2016-01-01 | 2016-12-31 | -15,813,000 | USD | 2018-03-16 | 10-K · 0001047469-18-001777 |
Related financial histories
- Traws Pharma, Inc.: total assets
- Traws Pharma, Inc.: total liabilities
- Traws Pharma, Inc.: stockholders equity
- Traws Pharma, Inc.: cash and cash equivalents
- Traws Pharma, Inc.: net income or loss
- Traws Pharma, Inc.: capital expenditure payments
- Traws Pharma, Inc.: revenue
- Traws Pharma, Inc.: financing cash flow
- Traws Pharma, Inc.: investing cash flow
- Traws Pharma, Inc.: retained earnings or deficit
- Traws Pharma, Inc.: basic weighted-average shares
- Traws Pharma, Inc.: diluted weighted-average shares
- Traws Pharma, Inc.: basic earnings per share
- Traws Pharma, Inc.: diluted earnings per share
- Traws Pharma, Inc.: income tax expense or benefit
- Traws Pharma, Inc.: net property, plant and equipment
- Traws Pharma, Inc.: share-based compensation expense
- Traws Pharma, Inc.: operating income or loss
- Traws Pharma, Inc.: current assets
- Traws Pharma, Inc.: interest expense
- Traws Pharma, Inc.: current liabilities
- Traws Pharma, Inc.: current accounts payable
- Traws Pharma, Inc.: operating expenses
- Traws Pharma, Inc.: research and development expense
Inspect the source
- Entity
- Traws Pharma, Inc. / CIK 0001130598
- Captured
- 2026-09-20T07:40:57.694Z
- SEC response SHA-256
c7aad4bae6948c123e86432faae3c4936a66036b64d2dcc75cc144be1c1002e5
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001130598.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))